Streetbeat News

Earnings

ALT

Altimmune, Inc. (NASDAQ:ALT) presented new data on pemvidutide's benefits for liver disease and obesity at the EASL Congress. The data showed significant improvements in liver health and body composition, suggesting pemvidutide's potential as a differentiated treatment for MASH and obesity.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:12 am

HROW

Harrow (NASDAQ:HROW) announced positive results from its ESSENCE-2 open-label extension clinical study for VEVYE, a cyclosporine ophthalmic solution for treating dry eye disease. The study demonstrated significant improvements in efficacy endpoints and high patient satisfaction, with minimal adverse events.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:10 am

VBNK

VersaBank reported its Q2 2024 financial results with a GAAP EPS of C$0.45, down from C$0.48 year-over-year. The bank's sales were C$28.501 million, missing the estimate of C$30.100 million.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:05 am

UNFI

United Natural Foods (UNFI) has provided its financial outlook for FY24, projecting net sales between $30.5 billion and $31 billion, compared to the estimated $30.78 billion. The company also forecasts adjusted EPS in the range of $(0.20) to $0.20, against the estimated $(0.06).

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:05 am

REVG

REV Group has lowered its FY24 outlook for net sales to a range of $2.40 billion to $2.50 billion, down from the previous range of $2.45 billion to $2.55 billion. The new estimate is below the consensus estimate of $2.49 billion.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:04 am

UNFI

United Natural Foods (UNFI) has lowered its net income and EPS expectations for the fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:02 am

REVG

REV Group (NYSE:REVG) reported Q2 2024 adjusted EPS of $0.39, beating the $0.26 estimate. Sales were $616.9M, surpassing the $601.459M estimate but down 9.44% from last year.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:01 am

UNFI

United Natural Foods (NYSE:UNFI) reported Q3 2024 adjusted EPS of $0.10, beating the estimate of $0.03. However, sales of $7.498 billion missed the $7.515 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:01 am

DIA

GLD

QQQ

SPY

USO

U.S. stock markets closed higher on June 4th, driven by weak labor market data that fueled expectations for a Federal Reserve rate cut. Most S&P 500 sectors ended higher, with notable gains in real estate, consumer staples, and information technology. Asian markets showed mixed results, while European markets advanced. Crude oil and gold showed minor gains.

Portfolio Pulse from Akanksha Bakshi

June 05, 2024 | 11:00 am

LE

Lands' End has revised its FY24 net revenue outlook from $1.33B - $1.45B to $1.36B - $1.45B, with an estimated $1.39B. The company also adjusted its EPS forecast from $0.10 - $0.38 to $0.18 - $0.41, with an estimated $0.19.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 10:55 am